Reasons To Attend
After back to back success of Drug Discovery conferences in Europe and USA, World BI welcomes you all to the inaugural Medicinal Chemistry Conference planned to take place on 28-29 November in Barcelona.
The Medicinal Chemistry Conference will prove to be a unique platform to meet senior level executives, key decision makers and experts all-around the Academic Institutions, Pharmaceutical, Biotech and lead researchers making the congress a perfect platform to share experience, foster collaborations to put forward many thought provoking strategies.
If you hope to discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world, there couldn’t be a better place for you to be on November 28-29 2019!
Benefits Of Sponsorship
Don't Take It From Us; Take It From Our Clients
Sai Life SciencesWe have thoroughly enjoyed the DDIP and the talks by various speakers. It was a truly wonderful experience to see various standpoints, out of the box thinking by several scientists, approaches to accelerate drug discovery and reasonable networking opportunities.
L’orealThe event was very well organized in a comfortable environment and atmosphere. The quality of the presentations was extremely good and respectful of the timing.
University of Beira InteriorThank you for having me at the 6th DDIP event. It was very informative and gave me a new perspective about the drug developments world on big pharma’s. It was also very important for research and busyness connecting.
DanPet ABI experienced a very positive and fresh meeting based on factors:
- Chairpersons were very competent and kept the pace including Q&A
- Topics were up to date – best about orphan drugs – positive heated debate – very interesting (!)
- Diversity of topics key – a good mix with borderline areas like cosmetics – very good
AstraZenecaIt was my pleasure to give the talk at the 6th DDIP in Frankfurt. I really enjoyed the conference and I think it was a great agenda with a lot of interesting and diverse talks.
AstraZenecaI enjoyed the meeting very much and it was very informative. I particular enjoyed the mix of the topics, which was unusual but generated a lot of engagement.
F. Hoffmann-La RocheIt was really a pleasure for me to attend this event. I like it very much due to the broad range of topics covered and also of the facility to interact with other participants.
Unique Conference Format
DDIP Expert Interview
Krishna Kanumuri - CEO at
I came to Sai Life Sciences from global telecom firm with a finance background to help with business development. It has been a remarkable experience working with all our great partners and being a small part of their success stories. In the 14 years I have been with Sai, it has been great to witness our transformation from a 30 member chemistry services provider to an integrated discovery, development and commercial service provider with over 2,000 employees.
At Sai, we truly focus on our partner’s success. Our fundamental belief is that we can add true investor value by building long terms customer relationships, as opposed looking at profitability at a transactional level. This ensures that we take a long term view of the business over a 10 year horizon, enabling us to make larger investments in the business and offering customers the framework to have a truly collaborative relationship. We are committed to our motto of “Making things better together”.
The rate of innovation is going to accelerate. The real game changer will be the ability of companies to be flexible and aggressive in adopting new technologies and getting products to market faster.
Talent is always a fundamental driver of company’s success. Our challenge will always be to attract and groom the best talent, while creating a supporting environment for them to truly excel.
Discovery Technologies: Placing the right bets on what technologies you want to adopt. Every move involves substantial investment and takes times to implement. This really presents some high risk reward choices companies will have to make.Information Technology: We are in a major transition phase where IT technology will be integral part of how we innovate and how we analyze data. Every company needs to develop the core IT architecture in their organizations now, if they want to stay relevant. Regulatory framework: The regulations are getting much more stringent. How do you stay fast and still ensure minimum regulatory risk.
It is now more critical than ever to stay current and really understand trends in the industry. DDIP is a great place for us to network and keep us at the front end of innovation trends.
Begin The Journey With A Call
- Access to the whole conference
- Access to the workshop
- Access to lunch and coffee sessions
- Access to Networking/Exhibition area
- Access to post-event conference presentations
- Marketing & Branding
To Avail All These
& Much More